LPTX News and Press, Leap Therapeutics Inc. From 03/16/20

Leap Therapeutics (NASDAQ: LPTX ): Q4 GAAP EPS of -$0.33 misses by $0.01 . More news on: Leap Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CAMBRIDGE, Mass. , March 16, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2019 . Leap Highlights...

"There's one more terrifying fact about old people: I'm going to be one soon ." - P. J. O'Rourke Today, we revisit a ' Tier 4 ' microcap biotech concern. The company had a horrid year in 2019 but has made some significant progress so far in 2020, even as its stock remains a roller coaster...

CAMBRIDGE, Mass. , Feb. 26, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli , Ph.D., Chairman, President and Chief Executive Officer, Dougl...

These Penny Stocks Have Been On The Move This Year Do penny stocks work ? Well, that depends on who you ask. Most new traders will likely have mixed things to say. Meanwhile, those who don’t trade penny stocks will tell you all of the bad ways they lost money. But then there are thos...

Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...

Sprint (NYSE: S ) +74%  after judge approves T-Mobile merger . More news on: Sprint Corporation, Rexahn Pharmaceuticals, Inc., ZK International Group Co., Ltd., Stocks on the move, Read more ...

Arcturus Therapeutics (NASDAQ: ARCT ) initiated with Outperform rating and $24 (96% upside) price target at Baird. More news on: Arcturus Therapeutics Holdings Inc., Curaleaf Holdings, Inc., I-Mab, Healthcare stocks news, Stocks on the move, , Read more ...

Gainers: AMKR   +14.5% . FLDM   +14.1% . LPTX   +7.5% . XPO   +3.6% . OMF   +3.4% . More news on: Amkor Technology, Inc., Fluidigm Corporation, Leap Therapeutics, Inc., Stocks on the move, , , News on ETFs Read more ...

CAMBRIDGE, Mass. , Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi , Chief Financial Officer, will present a corporate overview at...